| |
|
|
|
ADMA Biologics Inc.  
|
|
6.15 -0.42 (-0.06%) |
09-21 16:00 |
|
Open: |
6.55 |
Pre close: |
6.57 |
Target:
|
8.13
|
|
High: |
6.68 |
Low: |
6.15 |
Resistance:
|
6.96
8.13
|
|
Volume: |
208,686 |
Market Cap: |
285M |
Support:
|
5.89
5.22
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
6.43
 |
MACD |
MACD(12,26):
|
0.15 |
|
MA(20): |
6.32  |
Signal(12,26,9): |
0.18 |
|
MA(100): |
5.41 |
Stochastic Oscillator |
%K(14,3):
|
38.37 |
|
MA(250): |
4.33 |
%D(3): |
52.46 |
|
Average Volume(K) |
3-Month: |
25483
|
52-Week |
High:
|
6.96 |
|
10-Days: |
14704 |
Low: |
2.01 |
|
RSI |
RSI(14):
|
48.82 |
Change(%): |
85.2 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.350 |
Return on Equity (ttm) |
-153.0 |
Shares Out. (M) |
46.35 |
|
EPS Est. Current Year |
-1.740 |
Return on Assets (ttm) |
-60.0 |
Shares Float (M) |
46.12 |
|
EPS Est. Next Year |
-1.080 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.50 |
|
EPS Est. Next Quarter |
-0.370 |
Qtrly Rev. Growth |
37.0 |
% Held by Institutions |
70.80 |
|
Forward EPS |
-0.390 |
Gross Profit (p.s.) |
-0.142 |
Shares Short (K) |
1757 |
|
Book Value (p.s.) |
5.140 |
EBITDA (p.s.) |
-0.293 |
P/E |
-17.57 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.20 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-54.44 |
P/S |
419194848.00 |
|
Operating Margin |
-208.71 |
Levered Free Cash Flow
(M) |
-35.24 |
P/CF |
-5.24 |
|
|
|
|
|
|
